Effects of Tipranavir, Darunavir, and Ritonavir on Platelet Function, Coagulation, and Fibrinolysis in Healthy Volunteers

The use of HIV protease inhibitors (PIs) as part of antiretroviral therapy in the treatment of HIV-1 infection may be associated with an increased risk of bleeding. This prospective, randomized, open-label trial in healthy volunteers compared the effects of tipranavir/ritonavir (TPV/r), darunavir/ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kort, Jens J, Aslanyan, Stella, Scherer, Joseph, Sabo, John P, Kohlbrenner, Veronika, Robinson, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers Ltd 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343416/
https://www.ncbi.nlm.nih.gov/pubmed/21671884
http://dx.doi.org/10.2174/157016211796320306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343416/
https://www.ncbi.nlm.nih.gov/pubmed/21671884
http://dx.doi.org/10.2174/157016211796320306

Ejemplares similares